Miltiadis Zissis
About Miltiadis Zissis
Miltiadis Zissis is the CE Medical Lead and Medical Director at Bristol-Myers Squibb in New Jersey, United States, with extensive experience in gastroenterology and medical leadership across multiple countries.
Current Position at Bristol-Myers Squibb
Miltiadis Zissis is currently serving as both the Ce Medical Lead and Medical Director at Bristol-Myers Squibb in New Jersey, United States. In his role, he is involved in overseeing medical strategies and initiatives within the company, contributing to its overall mission in the pharmaceutical industry.
Previous Role at Merck Serono
From 2007 to 2011, Miltiadis Zissis worked as a Medical Director at Merck Serono in Darmstadt, Hessen, Germany. During his four-year tenure, he played a significant role in shaping the company's medical strategies and initiatives. His leadership contributed to the company's operations within the region.
Educational Background
Miltiadis Zissis has an extensive academic background in medicine. He studied at Ethnikon Kai Kapodistriakon Panepistimion Athinon, where he achieved a Doctor of Philosophy in Medicine. Additionally, he studied Medicine at Aristotle University of Thessaloniki from 1978 to 1984. His strong educational foundation has been pivotal in his medical career.
Experience in Gastroenterology
Miltiadis Zissis has an extensive background in gastroenterology, having worked in multiple hospitals in Greece over several years. His roles included positions at Alexandra Hospital (1998-2002), Aretaion Hospital (1996-1998), and Victoria Hospital as a Research Registrar (1995-1996). These positions provided him with significant clinical experience in the field.
Leadership Role at GE Healthcare
In 2007, Miltiadis Zissis held a short-term leadership position as Medical Director South Central Europe at GE Healthcare in Chicago, Illinois, United States. During his four-month stint, he focused on medical leadership in the South Central Europe region, contributing to the company's healthcare initiatives.